2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
20
INDUSTRY
4
OTHER_GOV
1
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
267
Neoplasms
177
Colorectal Neoplasms
133
Stomach Neoplasms
107
Uterine Cervical Neoplasms
96
Carcinoma, Non-Small-Cell Lung
89
Prostatic Neoplasms
83
Lung Neoplasms
78
Carcinoma, Hepatocellular
73
Rectal Neoplasms
64
Ovarian Neoplasms
54
Esophageal Neoplasms
53
Pancreatic Neoplasms
52
Colonic Neoplasms
52
Recurrence
43
Multiple Myeloma
39
Neoplasm Metastasis
38
Head and Neck Neoplasms
37
Endometrial Neoplasms
36
Precursor Cell Lymphoblastic Leukemia-Lymphoma
35
Motor Activity
34
Melanoma
33
Polycystic Ovary Syndrome
32
Lymphoma
32
Urinary Bladder Neoplasms
31
Leukemia, Myeloid, Acute
30
Thyroid Neoplasms
29
Small Cell Lung Carcinoma
28
Nasopharyngeal Carcinoma
25
Lymphoma, Non-Hodgkin
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Cytokine Release Syndrome
×
Clear all
NCT07502118
2026-03-30
NexCAR19
Health Institutes of Turkey
Phase 2/3
Recruiting
40 enrolled